During the past decade, Centre de Recherche du CHUS conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.7% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 1 clinical trials were completed. i.e. 6.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre de Recherche du CHUS" #1 sponsor was "Université de Sherbrooke" with 40 trials, followed by "Centre de recherche du Centre hospitalier universitaire de Sherbrooke" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Coloplast A/S" with 2 trials sponsored and "Abdenour Nabid" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre de Recherche du CHUS" #1 collaborator was "Centre de recherche du Centre hospitalier universitaire de Sherbrooke" with 3 trials as a collaborator, "Centre hospitalier de l'Université de Montréal (CHUM)" with 3 trials as a collaborator, "Laval University" with 3 trials as a collaborator, "McMaster University" with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Centre de Recherche du CHUS" are "Type 2 Diabetes" (6 trials), "Gestational Diabetes Mellitus" (5 trials), "Prostate Cancer" (4 trials), "Obesity" (3 trials) and "Cystic Fibrosis" (2 trials). Many other conditions were trialed in "Centre de Recherche du CHUS" in a lesser frequency.

Most popular intervention types in "Centre de Recherche du CHUS" are "Drug" (22 trials), "Other" (18 trials), "Procedure" (12 trials), "Behavioral" (7 trials) and "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Indirect calorimetry" (3 trials), "[U-13C]-palmitate" (3 trials), "liquid meal" (3 trials) and "2H-Glycerol" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre de Recherche du CHUS" are 38 trials for "All" genders, 10 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Centre de Recherche du CHUS". undefined are not yet recruiting, 12 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Centre de Recherche du CHUS, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Centre de Recherche du CHUS, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 24 trials that are defined as “Not Applicable".